DeutschNewstral
Article
The Hindu on 2020-05-09 22:39
Coronavirus | ICMR, Bharat Biotech tie up for Indian COVID-19 vaccine
Related news
- Coronavirus | Foreign envoys visit Bharat Biotech, Biological E vaccine facilities in HyderabadThe Hindu
- Bharat Biotech cuts vaccine price for States to ₹400/doseThe Hindu
Amid rising viral cases, Bharat Biotech working on H3N2 vaccineThe Times of India- Working on nasal vaccine as booster dose: Bharat BiotechThe Times of India
- Bharat Biotech submits intranasal vaccine data to drug regulatorThe Times of India
- Bharat Biotech inks pact with WU’s School of Medicine for COVID-19 intranasal vaccineThe Hindu
- Bharat Biotech begins clinical trials of more effective TB vaccine in IndiaThe Times of India
- Coronavirus | Bharat Biotech to pay compensation if Covaxin vaccine causes side effectsThe Hindu
- Covid vaccine: Bharat Biotech starts clinical trialsThe Times of India
- Bharat Biotech to submit trials' data to DCGI next weekThe Times of India
- Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacyThe Hindu
- Bid to fast-track vaccine development: ICMRThe Times of India
- Submitted all documents to WHO for EUL: Bharat BiotechThe Times of India
- ICMR nod to first Indian Covid test kitThe Times of India
- Indian diet, tea and turmeric lowered Covid deaths: ICMR studyThe Times of India
- ICMR invites bids to develop vaccine for monkeypox virusThe Hindu
- Death of Bhopal volunteer not due to vaccine, says Bharat BioTechThe Hindu
- Bharat Biotech says COVID-19 vaccine Covaxin shows 81% interim efficacyThe Hindu
- To test vaccine efficacy, ICMR isolating Omicron strainThe Times of India
- Coronavirus | Very few post-vaccine infections, says ICMRThe Hindu